Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brown

Showing results (561-570 of 597) with videos related to

Pageof 60
Sort By:
ESC Heart Failure|October 18, 2024
Association between clinician team segregation, receipt of cardiovascular care and outcomes in valvular heart diseasesIkeoluwapo Kendra Bolakale-Rufai, Shannon M Knapp, Janina Quintero Bisono, et al.
Journal of Medicinal Chemistry|March 7, 2007
Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamidesChuen Chan, Alan D Borthwick, David Brown, et al.
Ecohealth|February 4, 2025
Cross-Species Surveillance of Respiratory Viruses in Domestic and Wild Mammals of an Urban Atlantic Forest from BrazilLeonardo Corrêa da Silva Junior, Deborah Fernandes Wailante, Marina Galvao Bueno, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activityStephen P East, Clara Bantry White, Oliver Barker, et al.
Lancet (London, England)|March 6, 2004
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variantBen Lopman, Harry Vennema, Evelyne Kohli, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitorsNigel S Watson, David Brown, Matthew Campbell, et al.
Journal of the American College of Cardiology|June 20, 2020
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography SubstudyRaj R Makkar, Philipp Blanke, Jonathon Leipsic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2017
HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2Ariella B Hanker, Joan T Garrett, Mónica Valeria Estrada, et al.
The Journal of Pathology|April 9, 2015
Uncovering the genomic heterogeneity of multifocal breast cancerChristine Desmedt, Debora Fumagalli, Elisabetta Pietri, et al.
EMBO Molecular Medicine|December 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastomaKatarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos, et al.
Pageof 60

Showing results (561-570 of 597) with videos related to

Sort By:
Pageof 60
ESC Heart Failure|October 18, 2024
Association between clinician team segregation, receipt of cardiovascular care and outcomes in valvular heart diseasesIkeoluwapo Kendra Bolakale-Rufai, Shannon M Knapp, Janina Quintero Bisono, et al.
Journal of Medicinal Chemistry|March 7, 2007
Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamidesChuen Chan, Alan D Borthwick, David Brown, et al.
Ecohealth|February 4, 2025
Cross-Species Surveillance of Respiratory Viruses in Domestic and Wild Mammals of an Urban Atlantic Forest from BrazilLeonardo Corrêa da Silva Junior, Deborah Fernandes Wailante, Marina Galvao Bueno, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activityStephen P East, Clara Bantry White, Oliver Barker, et al.
Lancet (London, England)|March 6, 2004
Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variantBen Lopman, Harry Vennema, Evelyne Kohli, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Design and synthesis of orally active pyrrolidin-2-one-based factor Xa inhibitorsNigel S Watson, David Brown, Matthew Campbell, et al.
Journal of the American College of Cardiology|June 20, 2020
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography SubstudyRaj R Makkar, Philipp Blanke, Jonathon Leipsic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2017
HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2Ariella B Hanker, Joan T Garrett, Mónica Valeria Estrada, et al.
The Journal of Pathology|April 9, 2015
Uncovering the genomic heterogeneity of multifocal breast cancerChristine Desmedt, Debora Fumagalli, Elisabetta Pietri, et al.
EMBO Molecular Medicine|December 24, 2025
Repurposing statins and phenothiazines to treat chemoresistant neuroblastomaKatarzyna Radke, Kristina Aaltonen, Erick A Muciño-Olmos, et al.
Pageof 60